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ABSTRACT
OBJECTIVE: The objective of this selective EBM review is to determine whether or not tea
tree oil preparation an effective topical therapy for patients with MRSA colonized wounds.
STUDY DESIGN: This review is based on three randomized controlled trials (RCTs) published
in 2004,2013, and 2014. These studies compared the efficacy of tea tree oil (TIO) topical
preparations in MRSA colonized wounds.
DATA SOURCES: All articles used were published in English, in peer-reviewed journals, and
found using PubMed and Cochrane Review databases.
OUTCOMES MEASURED: The efficacy of tea tree oil preparations on MRSA colonized
wounds were evaluated by using data from conventional wound cultures and wound
measurements during and post treatments.
RESULTS: Dryden et al. (2004) found no significant difference between the two treatment
regimens (TTO vs Standard Treatment) when all patients and colonized sites were taken into
consideration. Blackwood et al. (2013) determined that washing patients with 5% TTO body
wash had no significant effect on the incidence of MRSA colonization in comparison to
Johnson's Baby Wash. On the contrary, Lee et al. (2014) found 10% TTO preparation was
successful in eliminating MRSA from colonized wounds. It was also determined that 10% TTO
preparation was successful in the recovery of chronic wounds that showed a delay in healing.
CONCLUSIONS: Results from two of the three studies demonstrate that there is no significant
difference in wound outcome for patients treated with TTO preparations versus standard
treatment methods. To further investigate whether TTO results is an effective topical therapy for
MRSA colonized wounds comparative studies with a larger sample size are needed.
KEY WORDS: Tea tree oil, MRSA, wounds, colonization, eradication, humans
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Introduction
Over the past three decades, tea tree oil (TIO) has claimed to have an antibacterial, analgesic,
and anti-inflammatory effects against Methicillin-resistant

Staphylococcus aureus (MRSA).l At a

concentration of 5%, reflecting the typical concentration of available solutions, TTO is known to
kill MRSA.2 TTO is also a popular "natural" antiseptic, suggesting that this agent may be useful
for skin antisepsis.

3

It is standard practice to attempt to clear MRSA with topical antimicrobials

and antiseptics, however, with an increase in usage of these agents, patients are becoming more
resistant to typical treatments.

3

This topic is relevant to patients and the PA practice because wound colonization with MRSA
is associated with high mortality in critically ill adults.' Of these critically ill adults with MRSA
colonized wounds, 60% subsequently develop a MRSA infection in the ICU setting.? As a health
care provider, it is our role to provide clinical interventions that will decrease the mortality of
patients. With a vast majority of ICU patients being affected with MRSA, it is imperative to
provide treatments that will decrease the likelihood of infecting other patients and providers
within the hospital setting.
The clinical spectrum of MRSA infection can range from asymptomatic colonization, to skin
and soft tissue infection, to life-threatening invasive infection." Patients affected by colonization
serve as a reservoir for transmission to others. Colonization can occur from contact with
contaminated wounds or dressing of infected individuals, contact with another individual's
colonized intact skin, contact with contaminated inanimate objects, and inhalation of aerosolized
droplets from chronic nasal carriers." MRSA can also be transmissible though contact with
medical equipment such as tourniquets, stethoscopes, and" blood pressure cuffs." As a future PA
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this is imperative because it illustrates how health care providers could inadvertently contrlbute
to the colonization ofMRSA in patients they provide care to.
As the field of healthcare expands the cost of clinical interventions for patients continue to
rise. National data indicate that hospitalizations for MRSA infection have increased 119% from
1999 through 2005.5 The median 6 months unadjusted cost for patients infected with MRSA was
$34,657 in 2005.5 Patients infected with MRSA spent more days hospitalized, received more
laboratory tests, imaging tests, physical medicine and rehabilitation services which lead to
increased medical bills.
Staphylococcus Aureus bacteria is one of the most common causes of skin infections in the
United States." In 2014, the CDC reported 72,444 incidents of invasive MRSA infections."
MRSA refers to types of staph that are resistant to a type of antibiotic methicillin." MRSA can
disrupt normal wound healing process, leading to prolonged wound healing. 1 Staph and MRSA
can cause an assortment of problems such as skin infections, sepsis, pneumonia, and bloodstream
infections."
The methods used to treat MRSA colonized wounds depend on the institution, but frequently
include combinations of the following: nasal mupirocin, chlorhexidine body wash, Johnson's
Baby Softwash, silver sulfadiazine 1% cream, and saline gauze dressing.' TTO preparations are
being proposed as a treatment method for MRSA-colonized wounds because of its known
effectiveness as an antimicrobial and skin antiseptic. TTO has been used for decades for other
skin conditions such as furuncles, superficial fungal infections, anaerobic vaginitis, and
eradication of head lice.' Due to the success TTO had with other medical conditions and proven

...

ability to kill MRSA, it is hypothesized that TTO can have the same success with MRSA
colonized wounds. MRSA is known to be resistant to numerous antibiotics, so providing an

..
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alternative method that is not resistant such as TTO could offer an improved treatment for
wounds.

6

Objective
The objective of this selective EBM review is to determine whether or not tea tree oil
preparation is an effective topical therapy for patients with MRSA colonized wounds.
Methods
Three randomized controlled trials were included in this systematic review. Articles for this
review were selected based on the population studied, TTO as the primary intervention, and
outcomes measured. In all three studies, the population consisted on men and women 16 and
older who had wounds colonized with MRSA. These studies all used TTO preparations at
varying concentrations to intervene against MRSA colonized wounds. Dryden et al. (2004)
selected a TTO regimen which consisted of 10% tea tree cream and 5% tea tree body wash
compared to the standard treatment regimen. The standard regimen comprised mupirocin 2%
nasal ointment applied to the anterior nares three times a day for five days, chlorhexidine
gluconate 4% soap applied all over the body at least once a day for five days, and silver
sulfadiazine 1% cream to skin lesions, wounds, leg ulcers once a day for five days." The TTO
regimen comprised tea tree 10% cream applied to the anterior nostrils three times a day for five
days; tea tree 5% body wash allover the body at least once a day for five days; tea tree 10%
cream to skin lesions, wounds and ulcers, and also to axillae or groins as an alternative to the
body wash.' Blackwood et al. (2013) utilized 5% TTO body wash (Novabac skin wash)
compared to Johnson's Baby Softwash where patients had at least one full bed bath daily with
the allotted wash.? Lee et al. (2014) utilized 10% TTO preparation compared to standard nonadhesive dressings. In the ITO group, the wound was cleansed gently with 0.9% normal saline

,

.
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to remove any debris and loose necrotic tissue, then 10% topical tea tree preparation applied onto
the wound surface.' In the comparison group, wounds were cleansed with 0.9% normal saline
before they were covered by a non-adhesive pad.'
Articles were researched via Pubmed and Cochrane Review databases. Selection of articles
was based on relevance to the clinical question, randomized controlled trials format, and
included patient-oriented outcomes (POEMS). Keywords entered included "MRSA," "colonized
wounds," "tea tree oil," and "humans." All selected studies were English language peer-reviewed
journal articles published in 2004-2014. Inclusion criteria for this systematic review include
primary literature published between 2000-present, addressed outcomes that matter to patients
(POEMS), and evaluated the efficacy ofTTO as a topical therapy for MRSA-colonized wounds
as a measured outcome. Exclusion criteria included previous Cochrane reviews, previous
students published systematic reviews, and wounds that were not MRSA colonized. Specific
exclusion criteria for each study is listed below in Table 1. Statistics reported in the Dryden et al.
(2004) and Lee et al. (2014) study include RBI, ABI, NNT, and p-value, Statistics for
Blackwood et al. (2013) include standard deviation, t-test values, and p-value. See Table 1 below
for Demographics and Characteristics of Included Studies.
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Table 1 - Demozranhlcs & Characteristics of
Type
#
Age
Inclusion
(years)
Patients
Criteria
RCT, 32
Mean ago All patients
with open
single
of control
pt
79.4
yo
chronic
-blind
study
(+1- 6.9)
wounds with
Mean age positivity in
toTTO
MRSA
group 81
wound
culture. If
yo (+17.6)
the pthad
multiple
wounds, the
largest
wound was
used.
RCT
445
18+
All patients
colonized
withMRSA
were eligible
for inclusion

RCT

224

16+

All patients
colonized
withMRSA
were eligible
for inclusion
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Included Studies
Exclusion Criteria
Patients suffering from
peripheral vascular
disease, using systemic or
topical antimicrobial
treatment, having clinical
signs of infection, and
more than 105 MRSA
bacteria per gram of
wound tissue being
detected from the MRSA
wound surface culture.
Wounds with undermining
or tunneling and known
sensitivity to tea tree oil.
Patients who were less
than 18 years of age; were
pregnant; were known to
be colonized with MRSA
on admission; were
unlikely to remain in the
ICU for at least 48h; were
known to have sensitivity
to TTO; declined consent;
were readmissions; or
were enrolled in another
trial of an Investigate
Medicinal Product (or
within the previous 30
days)
Patients who were unable
to give informed consent;
known to be sensitive to
tea tree oil; under the age
of 16; pregnant or
breastfeeding.

Withdraw
al
0

Interventions
10% Topical
tea tree oil
preparation
dressing vs.
standard nonadhesive
dressings

54

5% tea tree oil
body wash
(Novabac 5%
Skin wash) vs.
Johnson's
Baby Softwash

0

Mupirocin 2%
nasal ointment,
chlorhexidine
gluconate 4%
soap, and
silver
sulfadiazine
1% cream vs.
tea tree oil
regimen of tea
tree 10%
cream and tea
tree 5% body
wash
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Outcomes Measured
The outcome measured in this study was the efficacy of ITO preparation for the eradication
ofMRSA.1,2,3

Dryden et al. (2004) measured this outcome via swab for MRSA detection

collected from the nose, throat, axillae, groin creases, and any open skin lesions before starting
treatment, after the second day, and day 14 post treatment.'

Lee et al. (2014) achieved the

outcome by taking 5 measurements for MRSA bacterial count and wound healing condition at
baseline and 1 week intervals during the 4 week intervention period. 1 Wounds were measured
via the Pressure Ulcer Scale for Healing (PUSH) tool 3.0 and MRSA colonization determined
via wound culture with a sterile swab stick on the surface of wounds. 1 Blackwood et al. (2013)
study used new MRSA colonization during the inpatient episode in lCU, defined as detection of
MRSA by conventional culture methods in screening swabs of nose and groin, or in clinical
specimens processed by the laboratory during clinical care to measure the efficacy of ITO
preparations.' Blackwood et al. (2013) also examined the incidence ofMRSA bacteremia and
maximum increase in sequential organ failure assessment (SOFA) score with reference to
baseline assessment to determine the efficacy ofTTO preparation for MRSA-colonized wounds.'
Results
All three studies were performed using the methods previously outlined. Dryden et al. (2004)
study consisted of 224 participants in a hospital setting.' Non-eligible participants included those
unable to give informed consent, known to be sensitive to TTO, under age of 16, pregnant or
breastfeeding.' Treatment regimens and participant compliance were not closely monitored by
the investigating team.' Of the 114 participants that received standard treatment, 56 (49%) were
cleared of MRSA. 3 The remaining 110 participants that received TTO regimen 46 (41 %) were

...

cleared ofMRSA.3 For both groups the p-value was 0.0286, meaning both treatment group has

,
. /

.

Gerald

I TTO

and MRSA Colonization 9

statistically significant results. Mupirocin nasal ointment performed better than 10% tea tree oil
in nasal decolonization, while tea tree oil performed better than chlorhexidine in decolonizing the
skin lesions.' There were no incidents of adverse effects or treatment intolerance reports for the
nurses or patients. Table 2 summarize the results and efficacy of the Dryden et al. (2004) study.
Lee et al. (2014) study consisted of32 participants recruited from two non-government
nursing homes. 1 Participants excluded from the study included those with known sensitivity to
TTO or its major components, peripheral vascular disease, using systemic or topical
antimicrobial treatment, having sign of clinical infection, and more than 105 MRSA bacteria per
gram of wound tissue being detected from the surface culture.' Investigators did not report
compliance within the study. Throughout the five week duration of the study, TTO group had a
decrease in the mean viable count of MRSA. 1 Compared with the baseline, viable MRSA in
wounds at the first, second, third, and fourth weeks was reduced by 36%, 66%, 93% and 98%,
respectively.' In contrast, an increase in the mean viable count ofMRSA was noted in the control
group.' Compared with the baseline control group result, viable MRSA at the first, second, third,
and fourth measurements was increased by 26%, 39%, 53% and 60%, respectively.

I To

identify

the significant difference in MRSA eradication between the treatment groups one-way ANOV A
was used which revealed a statistically significant difference in treatment methods.' (See Table
3)
To determine the outcome of wound measurement, PUSH scores were used. A decline in
PUSH scores was noted in the TIO group with complete wound healing observed at week four.
Compared with baseline the percentage decreased at the first, second, third, and fourth
measurements were 30.4%, 31.6%, 87%, and 100% respectively.

I

Within the control group,

complete wound healing did not occur, but PUSH scores decreased. Compared to the baseline
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control group measurement, the wound size decreased 6.2%, 8.6%, 17.3%, and 43.2%
respectively.

I

To identify the significant difference in wound healing between the treatment

groups one-way ANOV A was used which revealed a statistically significant difference in
treatment methods.

I (See

Table 4). Table 2 summarizes the results and efficacy of the Lee et al.

(2014) study. There were no adverse effects reported throughout the study.
Table 2: Efficacy of TTO preparation on MRSA colonized wounds
Study

Dryden
Lee

Proportion
of patients
having
improvement
on standard
treatment
(CER)
31%
60%

Proportion
of patients
having
improvement
onTTO
preparations
(EER)
47%
98%

Relative
benefit
increase
(RBI)

Absolute
benefit
increase
(ABI)

Number
needed to
treat (NNT)

51.6%
0.633%

16%
38%

7
3

Table 3: One-way ANOV A comparing the control and TTO groups regarding quantity of
MRSA
Date recorded
Baseline
Week 1
Week 2
Week 3
Week 4

F
(1,30)
2.08
31.8
108
197.6
178.3

p-value
0.159
::;0.001
<0.001
<0.001
<0.001

Table 4: One-way ANOV A comparing the control and TTO groups regarding quantity of
MRSA
Date recorded
Baseline
Week 1
Week 2
Week 3
Week 4

F
(1,30)
0.59
9.37
40.81
80.67
71.60

p-value
0.810
<0.005
0.000
0.000
0.000
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Blackwood et al. (2013) study consisted of391 patients, 196 assigned to JBS group and 195
in the TTO group.' All patients were eligible for inclusion except those who: were less than 18
years of age, were pregnant, were known to be colonized with MRSA on admission, were
unlikely to remain in the ICU for at least 48 hours, were known to have sensitivity to TTO,
declined consent, were readmissions, or were enrolled in another trial of Investigative Medicinal
Product (or within the previous 30 days.)? At admission 445 patients were eligible for inclusion,
however 30 patients withdrew because of positive MRSA screen, 9 legal representatives declined
consent, and 11 patients were inappropriately randomized to the study.? Throughout the study,
two additional patients were withdrawn due to adverse events, a rash that was determined to be
unrelated to body wash, and two patients declined consent.' The study settings were two ICUs
and the patients presented with negative MRSA screening at admission. Investigators did not
follow compliance within the study. To determine the variance in MRSA colonization between
the TTO and Johnson's Body Softwash groups the investigators calculated the percentage
difference using Fisher's exact test and 95% confidence intervals.' Throughout the study, a total
of 39 patients, 22 JBS participants, and 17 TTO participants developed new MRSA colonization.
The difference in the percentage colonized was determined to be insignificant (see Table 3).2
There was no significant difference in the mean maximum increase in SOFA score between
groups, and no participants developed MRSA bacteremia. (See table 4)
Table 3: New MRSA Colonization

Patients with new
MRSA colonization

Percentage
Difference TTO vs.
JBS aroun
2.5%

95%CI

P value

(-8.95,3.94)

0.50
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Table 4: SOFA Scores

JBS Group

1.44

Standard
Deviation
1.92

TTOGroup

1.28

1.79

Sofa Score

Pvalue

0.85

Discussion
TTO is a known antimicrobial, antisepsis, and anti-inflammatory product used for skin
disorders. However, there is limited published evidence on the value and use ofTTO in a
contemporary medical setting. Common limitations to all three studies were the small sample
sizes, compliance not being measured throughout the studies, and short length of the clinical
trials. For example in the Blackwood et al. (2013) study, it would have taken investigators 9
years to recruit the desired sample size because the average accrual rate was only 19 patients per
month' Due to the limited sample size of this study investigators were unable to answer the
question of the effectiveness or TTO in preventing MRSA colonization.i Only Lee et al. (2014)
study found statistical significance for the use of TTO preparations on MRSA colonized wounds.
This could perhaps be contributed to the use of 10% TTO preparation, higher concentration than
other studies, or the low sample size of 32 participants.' Treatment blinding could not be applied
to the studies because of the distinctive smell of TTO preparations.
Conclusion
Based on this systematic review, evidence is inconclusive to prove that ITO is an effective
topical therapy for MRSA-colonized wounds. Even though ITO has been incorporated in a wide
variety of domestic products such as soaps, shampoo, and antiseptic creams to provide antifungal
and antibacterial protection it could not be concluded that ITO preparations were effective on
MRSA wounds.' Resistance to standard treatment regimens such as mupirocin and antibiotics are
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increasing so it is imperative to find an alternative treatment for MRSA colonization.' In this
review 5% and 10% TTO products were used which failed to provide complete eradication of the
MRSA wounds. Future studies should examine the use ITO preparations at higher
concentrations to see of MRSA eradication will occur since the ideal strength of TTO
preparations for MRSA eradication is unknown.

)
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